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A B S T R A C T
Ill or immunosuppressed hospital patients are at increased risk for herpes simplex and herpes zoster
virus infections, with high potential morbidity and mortality. Here, we present two cases of reactivation
of herpes virus infections with delay in diagnosis, with ultimately fatal results. Since these infections are
treatable, it is important to keep a high index of suspicion to facilitate early diagnosis and treatment.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Herpesviruses (family Herpesviridae) are linear, double strand-
ed DNA viruses that can establish latency in humans, and viral
reactivation may cause substantial morbidity and mortality. In this
report, we present two examples of cases of reactivation of herpes
virus infections in immunosuppressed or ill patients, with
ultimately fatal results. The ﬁrst case was diagnosed after several
days of hospitalization, and the second was only recognized
postmortem. Since these infections are treatable, a high index of
suspicion for herpes virus infections in hospitalized patients is
crucial for early diagnosis and treatment.
Case reports
Case 1
A 77-year-old woman with multiple medical problems,
including chronic lymphocytic leukemia (CLL), was admitted with
severe abdominal pain and emesis. Endoscopy revealed gastritis
with gastric ulcerations. A computed tomography (CT) scan
showed diffuse abdominal lymphadenopathy. The patient wasAbbreviations: ARDS, acute respiratory distress syndrome; BMT, bone marrow
transplant; CLL, chronic lymphocytic leukemia; CT, computed tomography; ECMO,
extracorporeal membrane oxygenation; HSV, herpes simplex virus; PCR, polymer-
ase chain reaction; TEN, toxic epidermal necrolysis; VZV, varicella zoster virus.
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2214-2509/ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article unleukopenic (white blood cell count 2600/mL) and thrombocytope-
nic (platelet count 78,000/mL) after recent ofatumumab chemo-
therapy, which targets cells expressing CD20. While hospitalized,
she became febrile and hypotensive and was treated for an E. coli
urinary tract infection. Several days after admission, she developed
a rash consisting of small erythematous macules and papules,
involving the face, trunk, upper arms, and upper thighs, with
biopsy consistent with varicella zoster. At that point, her clinical
picture was considered suspicious for disseminated varicella
zoster virus (VZV), and acyclovir therapy was initiated. During
hospitalization, her creatinine increased, she had a worsening
transaminitis, and her amylase and lipase were mildly elevated.
She became persistently febrile, diaphoretic, and dyspneic, and
died. Permission for autopsy was obtained.
At autopsy, the patient had innumerable erythematous macules
and papules on the skin of her face, trunk, and proximal limbs. Her
liver displayed numerous small hemorrhagic lesions of the capsule
and parenchyma (Fig. 1). Histologically, foci of necrosis were
present. Multifocal shallow ulcerations and mucosal erythema
were seen in the stomach. Patchy hemorrhage and necrosis were
present in the pancreas, with inﬂammation of peripancreatic
nerves. The liver, stomach, pancreas, and peripancreatic nerves all
showed strong positivity with immunohistochemical staining for
VZV, consistent with disseminated VZV with visceral involvement
(Fig. 2). Other autopsy ﬁndings included diffuse lymphadenopathy,
bone marrow lymphocytic aggregates (consistent with her known
CLL), and bladder erythema with mucosal hemorrhage.der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. External surface of liver, Case 1.
Fig. 2. Positive varicella zoster virus stain on section of peripancreatic nerves, Case 1.
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A 32-year-old woman with a history of type 1 diabetes and
stage IV chronic kidney disease was admitted for toxic epidermal
necrolysis syndrome. She had been treated with trimethoprim/
sulfamethoxazole a few weeks prior for dermatitis after a tick bite,
and presented to the hospital with fever and myalgias. After
treatment with doxycycline, she developed skin sloughing and
rash. She then developed multi-drug resistant Pseudomonas
necrotizing pneumonia, complicated by bronchopulmonary ﬁstu-
la. She underwent right anterior thoracotomy with lung resection
and debridement, but eventually developed progressive multi-
organ failure including the kidneys and lungs, as well as loss of skin
barrier function. She remained intubated, was treated with
multiple antimicrobials and vasopressors, and received high-dose
steroids. Despite being placed on extracorporeal membrane
oxygenation (ECMO), her pulmonary status did not improve,
and she died a few days later.
At autopsy, the patient had bilateral pulmonary consolidation
with diffuse parenchymal nodularity. There was right pleuralexudate and adhesions with residual necrotic parenchyma
adjacent to the site of her recent debridement and resection.
Histologically, the lungs showed diffuse necrotizing bronchopneu-
monia with multifocal necrotic and inﬂammatory infarcts with
cells displaying viral cytopathic effect suspicious for herpes
simplex virus (HSV). Bacterial cultures of the lungs grew
Pseudomonas aeruginosa. Lung tissue sent for molecular analysis
using polymerase chain reaction (PCR) was positive for HSV2 and
negative for HSV1.
The liver displayed numerous small foci of acute hepatocyte
necrosis with hemorrhage and apparent viral cytopathic effect.
PCR testing performed on liver tissue was positive for HSV2 and
negative for HSV1. The skin demonstrated generalized epidermal
desquamation consistent with toxic epidermal necrolysis (TEN);
however, microscopic examination showed viral cytopathic effect
consistent with HSV. Additionally, inﬂammation, necrosis, and
viral cytopathic effect were present in the trachea. Therefore, the
patient was proven to have HSV2 infection of the lungs and liver,
with likely involvement of the skin and trachea, in addition to
Pseudomonas pneumonia.
Discussion
Reactivation of herpes virus infections in immunosuppressed or
critically ill patients may cause substantial morbidity and
mortality. These two cases are examples with ultimately fatal
results. In the ﬁrst case, VZV was not diagnosed for several days
until a characteristic skin rash appeared, although visceral zoster
likely caused the patient’s presenting symptom of severe
abdominal pain. In the second case, infection with HSV2 was
not recognized until autopsy. Since these infections are treatable,
earlier recognition may have had impacted the clinical course.
Prior to varicella vaccination, over 90% of adults had been
exposed to VZV by their 20s and thus harbor latent infection in
their dorsal root ganglia [1], with risk for reactivation. Dissemi-
nated cutaneous zoster has been deﬁned as more than 20 vesicles
outside the area of the primary and adjacent dermatomes [2], or
involvement of 3 or more dermatomes. Visceral zoster can be
deﬁned as histologic or culture evidence of VZV and clinical
evidence of internal organ involvement in the setting of cutaneous
zoster [3]. Laboratory evidence can take the form of immunohis-
tochemical, direct immunoﬂuorescence, genetic, or culture posi-
tivity for VZV [4]. Internal organs affected may include the liver,
stomach, lungs, brain, and pancreas [4,5]. In case 1, the cause of
death was disseminated VZV infection with visceral involvement,
including hepatitis, gastritis, pancreatitis, peripancreatic neuritis,
and disseminated cutaneous disease.
Disseminated and visceral zoster are more common in
immunosuppressed individuals, cancer patients (especially those
with lymphoma and leukemia) [6], and transplant recipients [1].
Disseminated zoster can occasionally present in the absence of
known immunosuppression, and age-related declines in cellular
immunity may play a role [7]. This patient was at high risk due to
her hematologic malignancy, recent chemotherapy, and leukope-
nia. In combination with her age and other comorbidities,
reactivated zoster infection resulted in multiorgan failure and
death. Had clinical suspicion for zoster been present at admission,
prior to development of the characteristic rash, earlier initiation of
acyclovir therapy may have been helpful.
Similar cases have been previously reported in the literature.
Schiller et al. reported 3 cases of visceral VZV preceding cutaneous
symptoms in allogeneic bone marrow transplant (BMT) patients,
with life-threatening complications including hepatitis and
pancreatitis [3]. Stratman reported a case with gastric dissemina-
tion of VZV as the presenting symptom, and suggested that
“unexplained hepatitis, pancreatitis, gastritis, or complaints of
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prompt a high degree of suspicion for visceral zoster” [4].
Rusthoven et al. studied several hundred cases of VZV infection
in cancer patients, and found the highest risk of infection in
patients with leukemia and lymphoma [6]. They reported
disseminated disease in 12% of cases [6]. Rarely, disseminated
zoster has been reported even in immunocompetent patients [7].
Disseminated visceral zoster is associated with a high mortality
rate; for example, 55% of those affected died in one 1985 study of
BMT patients [8]; in contrast, pure cutaneous dissemination is
rarely fatal.
In case 2, the patient had toxic epidermal necrolysis (TEN),
presumably associated with antimicrobial use, then developed a
necrotizing pneumonia during her hospitalization. Her antemor-
tem cultures repeatedly grew multi-drug resistant Pseudomonas
aeruginosa, despite treatment with several broad-spectrum anti-
microbials, with cavitary disease requiring debridement. Pseudo-
monas pneumonia is unusual in otherwise healthy individuals, but
is a common nosocomial pathogen in ill and immunosuppressed
patients [9,10]. The patient had received high-dose steroids for her
TEN, which likely contributed to immunosuppression.
At autopsy, the presence of viral cytopathic effect consistent
with HSV in the patient’s lungs, liver, trachea, and skin was an
unexpected ﬁnding. Postmortem lung and liver tissue tested
positive for HSV2 by PCR. HSV1 has a seroprevalence of 50 to 80%
among adults, with HSV2 seroprevalence of 15 to 50% depending
on age, gender, and race [1], and 22% overall in US adults [11].
Hence, reactivation disease is possible in the majority of patients.
HSV can cause pneumonia, hepatitis, and disseminated visceral
disease, especially in immunosuppressed patients. It can be
difﬁcult to diagnose in the absence of cutaneous lesions, and is
often fatal [5].
In the literature, Kusne et al. reported 12 cases of HSV hepatitis,
where 8 patients died and 7 of those were not diagnosed with HSV
until autopsy or within 24–48 h of death [12]. Fatal HSV2 hepatitis
has also been reported in a heart transplant recipient [13]. Luyt
et al. studied non-immunocompromised patients receiving me-
chanical ventilation for >5 days, and found that 21% of those who
deteriorated clinically had HSV bronchopneumonitis [14]. Addi-
tional studies have shown HSV positivity in the upper respiratory
tract of intensive care patients is associated with worse outcomes,
including increased length of stay, acute respiratory distress
syndrome (ARDS), and reduced survival [15,16].
In our patient, untreated visceral HSV infection superimposed
on her Pseudomonas pneumonia could explain a progressive
decline despite appropriate antimicrobial treatment. Of note, HSV
can be associated with TEN [17,18]; however, antimicrobials are a
more likely etiology based on the history in this case, especially
since viral cytopathic effect was not noted on an early skin biopsy.
Premortem recognition of this infection, and initiation of
appropriate antiviral therapy, may have been clinically beneﬁcial.
Conclusion
Given the protean manifestations of herpes simplex and herpes
zoster infections, their potential morbidity and mortality, and the
increased risk in ill or immunosuppressed hospital patients, it is
important to keep a high index of suspicion to facilitate early
diagnosis and treatment.Competing interests
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